Abstract:The identification of a biologic substrate for maintaining hepatocyte functions is essential to provide reliable and predictable models for in vitro drug screening. In the current study, a three-dimensional culture of hepatocytes was established on highly porous fibrous scaffolds with grafted galactose and RGD to afford extensive cell-cell and cell-scaffold interactions spatially. The pore size and ligand densities indicated significant effects on the formation of hepatocyte spheroids in balancing the cell retention, adhesion, and migration on fibrous scaffolds. Fibrous scaffolds with an average pore size of 60 μm and surface grafting densities of galactose at 5.9 nmol/cm(2) and RGD at 6.9 pmol/cm(2) provided optimal microenvironments for hepatocyte infiltration and multicellular spheroid formation. Significant promotions were also demonstrated in the syntheses of albumin and urea and the activities of phase I (CYP 3A11 and CYP 2C9) and phase II enzymes. The in vitro metabolism tests on testosterone and acetaminophen by hepatocytes on the optimal scaffolds indicated the predicated clearance rates of 50.7 and 22.6 ml/min/kg, respectively, which were comparable to the in vivo values of rats. The in vitro hepatotoxicity tests on amiodarone hydrochloride and acetaminophen predicted the half maximal effective concentrations (EC50) to reflect the in vivo toxic plasma concentrations in human. In addition, the enzyme activities, predicted clearance rates and hepatotoxicity values of hepatocytes on the optimal scaffolds experienced sensitive responsiveness to specific inducers or inhibitors of CYP 3A11 and phase II enzymes, exhibiting in vivo-in vitro correlations to a certain extent. These results demonstrate the feasibility of hepatocyte spheroid culture on fibrous scaffolds as an potential in vitro testing model to predict the in vivo drug metabolism, hepatotoxicity, and drug-drug interactions.

Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism.

Human iPSC-derived liver co-culture spheroids to model liver fibrosis

Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease

A Novel 3d Liver Organoid System for Elucidation of Hepatic Glucose Metabolism

Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease

A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates

Human Liver Organoid: Modeling Liver Steatosis and Beyond

Development of alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell derived liver organoids

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Hepatocyte Spheroid Culture on Fibrous Scaffolds with Grafted Functional Ligands As an in Vitro Model for Predicting Drug Metabolism and Hepatotoxicity

3D culture models to study pathophysiology of steatotic liver disease

Modeling alcohol-associated liver disease in humans using adipose stromal or stem cell-derived organoids

In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line

Organoid-guided Precision Hepatology for Metabolic Liver Disease

Establishment of Functional Liver Spheroids From Human Hepatocyte-Derived Liver Progenitor-Like Cells for Cell Therapy